Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cacabelos

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Annals of the New York Academy of Sciences|September 24, 1993
Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementiaR Cacabelos, X A Alvarez, A Franco-Maside, et al.
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1991
Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disordersR Cacabelos, M Barquero, P García, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral changes associated with different apolipoprotein E genotypes in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Anapsos reverses interleukin-1 beta overexpression and behavioral deficits in nbM-lesioned ratsX A Alvarez, A Franco-Maside, R Zas, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1990
Antagonistic effects of growth hormone-releasing factor (GRF) and somatostatin on locomotor activity: GRF-induced hyperkinetic syndromeR Cacabelos, H Niigawa, X A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1992
Serum histamine in Alzheimer's disease and multi-infarct dementiaR Cacabelos, L Fernández-Novoa, J M Pérez-Trullén, et al.
Methods and Findings in Experimental and Clinical Pharmacology|March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementiaR Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystoniaK Beyer, J I Lao-Villadóniga, B Vecino-Bilbao, et al.
Annals of the New York Academy of Sciences|January 17, 1996
Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsR Cacabelos, J Caamaño, M J Gómez, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Annals of the New York Academy of Sciences|September 24, 1993
Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementiaR Cacabelos, X A Alvarez, A Franco-Maside, et al.
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1991
Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disordersR Cacabelos, M Barquero, P García, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral changes associated with different apolipoprotein E genotypes in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Anapsos reverses interleukin-1 beta overexpression and behavioral deficits in nbM-lesioned ratsX A Alvarez, A Franco-Maside, R Zas, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1990
Antagonistic effects of growth hormone-releasing factor (GRF) and somatostatin on locomotor activity: GRF-induced hyperkinetic syndromeR Cacabelos, H Niigawa, X A Alvarez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1992
Serum histamine in Alzheimer's disease and multi-infarct dementiaR Cacabelos, L Fernández-Novoa, J M Pérez-Trullén, et al.
Methods and Findings in Experimental and Clinical Pharmacology|March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementiaR Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1997
A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystoniaK Beyer, J I Lao-Villadóniga, B Vecino-Bilbao, et al.
Annals of the New York Academy of Sciences|January 17, 1996
Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsR Cacabelos, J Caamaño, M J Gómez, et al.
Pageof 11